Valuation: GI Innovation, Inc.

Market Cap 44TCr 32Cr 29Cr 26Cr 24Cr 45Cr 3.01TCr 47Cr 315.99Cr 126Cr 1.6TCr 120.04Cr 117.47Cr 5.06TCr P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 40TCr 29Cr 26Cr 24Cr 22Cr 42Cr 2.77TCr 43Cr 290.9Cr 116Cr 1.48TCr 110.51Cr 108.14Cr 4.66TCr EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.32%
Yield 2024 *
-
Yield 2025 -
1 day-1.46%
1 week+0.45%
Current month+0.45%
1 month-24.13%
3 months-20.94%
6 months-54.08%
Current year-61.68%
1 week 5,710
Extreme 5710
7,050
1 month 5,710
Extreme 5710
8,670
Current year 5,710
Extreme 5710
18,830
1 year 5,710
Extreme 5710
20,950
3 years 5,710
Extreme 5710
24,900
5 years 5,710
Extreme 5710
24,900
10 years 5,710
Extreme 5710
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 54 16/06/2021
Director/Board Member 58 01/07/2017
Director/Board Member 64 01/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/01/26 Expiration 14 0.0000% -
20/01/26 Exercice

Chief Technology Officer

445 0.0007%
20/01/26 Exercice 14 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.46%+0.45%-55.85%-22.90% 32Cr
-4.83%+3.51%+55.00%+63.79% 6.67TCr
+0.02%+1.07%+11.72%+75.63% 5.69TCr
-1.34%+2.98%+25.08%+100.18% 5.65TCr
+5.09%+9.89%+27.19%+105.85% 4.65TCr
+2.62%+1.68%+29.16%+35.86% 4.48TCr
+8.24%+0.51%+215.16%+794.74% 4.16TCr
-1.86%+10.13%+28.14%+55.48% 3.53TCr
-2.97%-9.84%+90.91%+73.49% 3.33TCr
+5.19%+1.62%-39.69%+368.87% 2.51TCr
Average +0.87%+2.31%+38.68%+165.10% 4.07TCr
Weighted average by Cap. +0.65%+3.07%+49.82%+165.73%

Financials

2024 2025
Net sales 2.43Cr 17.81T 15.97T 14.6T 13.32T 25.1T 16.74L 25.89T 2L 70.15T 9L 66.83T 65.4T 28.19L 583.81Cr 42.81L 38.4L 35.09L 32.03L 60.35L 40Cr 62.26L 4.23Cr 1.69Cr 21Cr 1.61Cr 1.57Cr 68Cr
Net income -5.88TCr -4.31Cr -3.87Cr -3.53Cr -3.23Cr -6.08Cr -405.22Cr -6.27Cr -43Cr -17Cr -216.22Cr -16Cr -16Cr -682.58Cr -3.51TCr -2.58Cr -2.31Cr -2.11Cr -1.93Cr -3.63Cr -242.2Cr -3.75Cr -25Cr -10Cr -129.23Cr -9.67Cr -9.46Cr -407.97Cr
Net Debt -343.96Cr -25.22L -22.62L -20.68L -18.87L -35.56L -24Cr -36.68L -2.49Cr -99.37L -13Cr -94.67L -92.64L -40Cr -3.46TCr -2.54Cr -2.28Cr -2.08Cr -1.9Cr -3.58Cr -238.69Cr -3.69Cr -25Cr -10Cr -127.36Cr -9.53Cr -9.33Cr -402.07Cr
Projected Income Statement - Annual - GI Innovation, Inc.
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
06/26/06 ₩6,760.00 -1.46% 5,45,095
05/26/05 ₩6,860.00 +10.29% 9,35,665
04/26/04 ₩6,220.00 -1.74% 6,48,469
03/26/03 ₩6,330.00 -7.05% 5,25,077
02/26/02 ₩6,810.00 +1.19% 2,20,740
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock